Table 1.
Clinical features | Number | NAT10 | Positive rate (%) | Z/χ2 | P | ||
---|---|---|---|---|---|---|---|
Negative | Low | High | |||||
Sex | 0.265 | 0.791 | |||||
Male | 80 | 6 | 28 | 46 | 92.5 | ||
Female | 20 | 2 | 7 | 11 | 90.0 | ||
Age | 0.542 | 0.588 | |||||
≤60 years | 48 | 2 | 18 | 28 | 95.8 | ||
>60 years | 52 | 6 | 17 | 29 | 88.5 | ||
History of hepatitis | 7.217 | 0.027* | |||||
Positive | 76 | 3 | 27 | 46 | 96.0 | ||
Negative | 24 | 5 | 8 | 11 | 79.0 | ||
History of cirrhosis | 8.371 | 0.015* | |||||
Positive | 78 | 3 | 29 | 46 | 96.2 | ||
Negative | 22 | 5 | 6 | 11 | 77.3 | ||
Tumor size | 1.139 | 0.255 | |||||
≤5 cm | 59 | 5 | 23 | 31 | 91.5 | ||
>5 cm | 40 | 3 | 11 | 26 | 92.5 | ||
Differentiation | 2.166 | 0.339 | |||||
Low | 30 | 2 | 13 | 15 | 93.3 | ||
Middle | 64 | 6 | 21 | 37 | 90.6 | ||
High | 6 | 0 | 1 | 5 | 100.0 | ||
Single/Multiple tumor | 1.416 | 0.157 | |||||
Single | 83 | 8 | 30 | 45 | 90.4 | ||
Multiple | 17 | 0 | 5 | 12 | 100.0 | ||
AFP | 0.987 | 0.324 | |||||
Normal | 43 | 6 | 14 | 23 | 86.0 | ||
Abnormal | 57 | 2 | 21 | 34 | 96.5 | ||
ALT | 1.296 | 0.195 | |||||
Normal | 35 | 2 | 10 | 23 | 94.3 | ||
Abnormal | 65 | 6 | 25 | 34 | 90.8 | ||
AST | 0.304 | 0.761 | |||||
Normal | 40 | 4 | 12 | 24 | 90.0 | ||
Abnormal | 60 | 4 | 23 | 33 | 93.3 |
NAT10 N-acetyltransferase 10, AFP alpha-fetoprotein, ALT alanine aminotransferase, AST aspartate aminotransferase.
*p value <0.05.